LunarLock Prime 7-Year review

Yes, for buyers who genuinely have a seven-year time horizon and want a guaranteed rate without complexity. This is a clean, no-frills MYGA-type product from a carrier with A-rated financial strength. It is not a good fit for buyers who are uncertain about their liquidity needs, who want index-linked upside, or who are shopping for rider-based lifetime income. The rate banding rewards larger contracts, and the nursing home waiver adds a layer of flexibility that shorter fixed annuities rarely include.

The core reason to buy LunarLock Prime 7-Year is certainty. Buyers get a guaranteed rate locked for the full seven-year term with no possibility of the carrier resetting it lower, no cap or participation structure to monitor, and no annual fees. The rate tiers mean that buyers placing $100,000 or more are rewarded with a meaningfully higher rate. For a retiree or pre-retiree who wants a portion of their portfolio delivering a known annual return — closer in behavior to a CD than to an indexed product — this design makes the decision straightforward.

I think LunarLock Prime 7-Year is best suited for buyers in their 50s and 60s with a defined pool of long-term money they are not planning to touch for seven years. That could be a rollover IRA, a pension lump sum, or non-qualified savings earmarked for retirement. The wide issue-age range (18-88) is notable — the product accommodates older buyers who want guaranteed accumulation without requiring joint annuitant workarounds. It is less attractive for someone who wants annual access to more than 10% of the contract, who anticipates needing a large lump sum during the surrender period, or who is shopping for growth potential tied to an index.

You are buying a contract that works like a CD but with tax-deferred growth and insurance company guarantees. The carrier locks your rate for seven years — neither up nor down — and credits that rate annually to your account value. What you are not buying is market upside, rider-based income, or any flexibility to reallocate across strategies. The simplicity is the product. For buyers who understand that, the decision is mostly about whether AuguStar's rate is competitive against other fixed annuities and MYGA options in the same duration band.

LunarLock Prime 7-Year credits interest at a fixed declared rate that is guaranteed for the full contract term. There are two rate tiers based on premium size: the standard tier for premiums below $100,000 and a higher tier for premiums of $100,000 or more. Based on the product materials, current declared rates were 4.90% for the standard tier and 5.10% for the $100,000-plus tier, guaranteed for all seven years.

Because the rate is fixed and guaranteed, there are no crediting method decisions to make after purchase. The buyer receives that rate each contract year regardless of what happens in the broader interest rate environment. That guarantee is also the source of the product's main structural risk: if rates rise materially, you are locked into a lower fixed return and face surrender charges and a potential MVA to exit early.

The nursing home confinement waiver is the most meaningful secondary feature here. It allows contract holders who are confined to a nursing facility for at least 30 consecutive days — beginning after the first contract anniversary — to access their funds without the normal surrender charges. That matters because the most common reason a buyer in their 60s or 70s might need to break a long-term annuity early is a health event. The waiver applies to buyers from age 18 to 80 at the time of issue, which covers most of the realistic buyer profile. It does not eliminate every early-exit risk, but it addresses the scenario that is likely to matter most.

LunarLock Prime 7-Year is a seven-year commitment. The surrender charge schedule starts at 9% in year one and steps down annually — 9%, 8%, 7%, 6%, 5%, 4%, 3%, then 0% — so the contract fully surrenders charge-free after year seven. An MVA — Market Value Adjustment — also applies, meaning the effective cost of an early exit fluctuates with interest rates. In a rising rate environment, the MVA can add to the surrender penalty; in a falling rate environment, it may reduce it.

The 10% annual free-withdrawal provision gives meaningful flexibility. In years two through seven, up to 10% of the account value as of the prior contract anniversary can be withdrawn without triggering surrender charges. In the first year, the allowance is 10% of premium paid. Required minimum distributions from qualified accounts may also be taken without incurring surrender charges, which is a practical feature for IRA holders who must take RMDs.

Buyers who have any real possibility of needing access to more than 10% of the contract during the seven-year period should weigh that risk carefully before committing. The nursing home waiver covers the most acute health scenario, but there is no terminal illness waiver mentioned in the product materials.

There are no base contract fees and no rider fees on LunarLock Prime 7-Year. The guaranteed rate is credited net — buyers do not see an explicit fee line item subtracted from their account. The implicit cost is the spread between what the carrier earns on invested assets and what it pays out as the declared rate, which is standard for all MYGA-type products and not unique to this contract.

The real tradeoffs are structural. Seven years is a longer commitment than most fixed annuities in the 3-5 year band, and the MVA adds uncertainty to early exits beyond what the printed surrender schedule suggests. Buyers who are locked in as rates rise will hold a below-market rate for the duration. That is not a defect — it is the nature of a fixed-rate contract — but it is the main tradeoff worth understanding before purchasing.

Legal Entity: AuguStar Life Insurance Company

Parent: Constellation Insurance

A.M. Best Rating: A